HealthEquity (MEX:HQY) Cyclically Adjusted Revenue per Share: MXN276.78 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:HQY HealthEquity Inc MEX:HQY
96 GF Score
Price MXN2,150.00
GF Value MXN2,143.43
! 4 Warning Signs
View Full Analysis

What is HealthEquity Cyclically Adjusted Revenue per Share?

HealthEquity MEX:HQY 96 Cyclically Adjusted Revenue per Share is MXN276.78 as of Apr. 2026. GuruFocus rates MEX:HQY with a GF Score™ of 96/100 and a GF Value™ of MXN2,143.43. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

HealthEquity's adjusted revenue per share for the three months ended in Apr. 2026 was MXN73.076. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN276.78 for the trailing ten years ended in Apr. 2026.

During the past 12 months, HealthEquity's average Cyclically Adjusted Revenue Growth Rate was 17.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 18.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of HealthEquity was 18.10% per year. The lowest was 18.10% per year. And the median was 18.10% per year.

As of today (2026-08-17), HealthEquity's current stock price is MXN2150.00. HealthEquity's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 was MXN276.78. HealthEquity's Cyclically Adjusted PS Ratio of today is 7.77.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of HealthEquity was 13.12. The lowest was 7.38. And the median was 10.03.


HealthEquity  (MEX:HQY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

HealthEquity's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2150.00/276.78
=7.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of HealthEquity was 13.12. The lowest was 7.38. And the median was 10.03.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


HealthEquity Cyclically Adjusted Revenue per Share Related Terms


HealthEquity Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for HealthEquity's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity Cyclically Adjusted Revenue per Share Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 251.21

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 207.02 220.27 251.21 276.78

MEX:HQY vs TEM, TXG, HNGE: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, HealthEquity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HealthEquity's Cyclically Adjusted PS Ratio falls into.


MEX:HQY
96GF Score
HealthEquity Inc MEX:HQY
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HealthEquity's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=73.076/333.0200*333.0200
=73.076

Current CPI (Apr. 2026) = 333.0200.

HealthEquity Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 13.897 240.628 19.233
201610 13.562 241.729 18.684
201701 16.123 242.839 22.110
201704 17.090 244.524 23.275
201707 16.446 244.786 22.374
201710 17.559 246.663 23.706
201801 18.062 247.867 24.267
201804 20.931 250.546 27.821
201807 20.848 252.006 27.550
201810 22.337 252.885 29.415
201901 23.064 251.712 30.514
201904 25.876 255.548 33.721
201907 25.086 256.571 32.561
201910 42.717 257.346 55.278
202001 52.523 257.971 67.803
202004 63.026 256.389 81.864
202007 54.085 259.101 69.515
202010 49.019 260.388 62.692
202101 48.416 261.582 61.638
202104 45.447 267.054 56.673
202107 44.956 273.003 54.839
202110 44.263 276.589 53.294
202201 50.116 281.148 59.362
202204 49.837 289.109 57.406
202207 49.710 296.276 55.875
202210 50.713 298.012 56.670
202301 51.885 299.170 57.756
202304 51.064 303.363 56.056
202307 47.159 305.691 51.375
202310 51.642 307.671 55.897
202401 51.385 308.417 55.484
202404 55.564 313.548 59.015
202407 62.923 314.540 66.620
202410 67.898 315.664 71.631
202501 72.101 317.671 75.585
202504 73.310 320.795 76.104
202507 69.801 323.048 71.956
202510 68.702 0.000
202601 67.112 325.252 68.715
202604 73.076 333.020 73.076

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN276.78 mean?
HealthEquity (MEX:HQY) has a Cyclically Adjusted Revenue per Share of MXN276.78 as of Apr. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on HealthEquity and its competitors.
Is HealthEquity's Cyclically Adjusted Revenue per Share too high?
HealthEquity's current Cyclically Adjusted Revenue per Share is MXN276.78. Overall, HealthEquity has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Cyclically Adjusted Revenue per Share compare to TEM and TXG?
HealthEquity's Cyclically Adjusted Revenue per Share of MXN276.78 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on HealthEquity and its competitors. HealthEquity's current Cyclically Adjusted Revenue per Share is MXN276.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (MEX:HQY) has a current Cyclically Adjusted Revenue per Share of MXN276.78. The stock's GF Value™ is MXN2,143.43, compared to a current price of MXN2,150.00 — trading 0.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN276.78. HealthEquity's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For HealthEquity (MEX:HQY), the current Cyclically Adjusted Revenue per Share is MXN276.78 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (MEX:HQY) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be overvalued. The current stock price of MXN2,150.00 is trading 0.3% above its estimated GF Value™ of MXN2,143.43.

Key valuation signals for MEX:HQY:

  • Cyclically Adjusted Revenue per Share: MXN276.78
  • GF Value™: MXN2,143.43 vs. price of MXN2,150.00 (0.3% above fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the MEX:HQY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
96GF Score

Get the complete analysis for MEX:HQY

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,150.00
Price
MXN2,143.43
GF Value